Leadership and researchers at the Princess Margaret Cancer Consortium present updates to Network

Last Thursday, Feb. 29, leadership and researchers from the Princess Margaret Cancer Consortium in Ontario presented organization and scientific updates to Network members as part of MOHCCN Seminar Series.

This series, which will be held year-round, features virtual talks from MOHCCN research partner investigators and trainees from each region, providing a platform for MOHCCN members to share their ongoing work in precision oncology with the wider Network.

The event was co-chaired by Yuan Lew, members of the MOHCCN Patient Working Group and Dr. Véronique LeBlanc, Network Program Manager and Scientific Writer.

Watch the full video

Speakers

PM2C CONSORTIUM ACTIVITIES UPDATE

• Dr. Lillian Siu - Medical Oncologist, Princess Margaret Cancer Centre (PMCC), University Health Network (UHN); MOHCCN consortium lead (PM2C)
• Dr. Amber Simpson - Associate Professor, Queen's University; Canada Research Chair in Biomedical Computing and Informatics; MOHCCN Kingston / Queen's University institutional lead

RESEARCH PRESENTATIONS

• Identification and clinical implications of circular RNA in cancer
  • Dr. Hansen He - Senior Scientist, PMCC, UHN; Professor, Department of Medical Biophysics, University of Toronto; MOHCCN cohort lead
  • View abstract and plain language summary
• Shedding light on the surge: Investigating the etiology of young onset colorectal cancer
  • Dr. Kevin Wang - Medical Oncology Fellow, Eliot Phillipson Clinician-Scientist Training Program, PMCC, UHN
  • View abstract and plain language summary